Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
MediGene
Officials from MediGene recently report on new developments
April 11th, 2007
Officials from MediGene recently report on new developments. This trend article is an immediate alert from NewsRx to identify the most recent news developments at MediGene. Report 1: Today the German-American biotech company MediGene AG (Frankfurt, Prime Standard: MDG) announced that the European patent office has granted a patent covering the drug candidate EndoTAGTM-1. The patent protects the substance EndoTAG(TM)-1 developed by MediGene as a drug for the treatment of various types of cancer. Dr. Peter Heinrich, Chief Executive Officer of MediGene AG, comments: "MediGene now enjoys extensive patent protection for EndoTAG(R)-1 in...
Source: Medical Patent Law Weekly (2007-04-11)
|
